Comparative Analysis of Vaccination Status in Enteric Fever: Correlating Clinical and Laboratory Parameters


  • Nixat Patel Government Medical College, Surat, India
  • Khyati Sasani Nirmal hospital, Surat city, India
  • Swapnil Shah Nirmal hospital, Surat city, India



Enteric fever, Hepatitis vaccine, Salmonella typhi, Immunization, Hepatitis


Introduction: The emergence of resistant haplotypes of Salmonella makes control via vaccination an urgent priority. This study was conducted to evaluate the clinical and investigative profile of enteric fever cases admitted during study period at Nirmal hospital private limited, Surat and their typhoid immunization status to assess difference in presentation and clinic-investigation profile between immunized and unimmunized group.

Methodology: This cross-sectional study conducted among children admitted with enteric fever. All the children were assessed for hepatitis vaccination status. Clinical and laboratory parameters were correlated with vaccination status.

Results: Out of 101 study subjects, only 19 (18.81%) were immunized with any of the typhoid vaccine. Signs-symptoms and complications were not associated with immunization status (p > 0.05). Lower hemoglobin level and higher WBC count were associated with immunization status (p <0.05). The mean difference in Absolute Eosinophil Count was found statistically insignificant. (p 0.109) between two groups.

Conclusion: The enteric fever is more common in school going age group of 5-14 years of age. Vaccination against typhoid provides protection against infection with S. Typhi. Vaccination can also help to reduce anemia during episode of enteric fever.


Parry CM. Epidemiological and clinical aspects of human ty-phoid fever. Salmonella infections: clinical, immunological and molecular aspects. 2006. Doi: PMid:17190609

Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, Ochieng JB, Wamola N, Bigogo GM, Awiti G, Tabu CW, Burke H. Popu-lation-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PloS one. 2012 Jan 19;7(1):e29119. Doi: PMid:22276105 PMCid:PMC3261857

Atul Kothari,Amitpruthi, Tushi D. The burden of enteric fever. J. Infect. Dev. Ctries. 2008; 2:253-9. Doi: PMid:19741285

Kothari A, Pruthi A, Chugh TD. The burden of enteric fever. The Journal of Infection in Developing Countries. 2008 Aug 1;2(04):253-9. Doi: PMid:19741285

Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai-clinical profile, sensitivity patterns and response to antimicrobials. JAPI. 2008 Apr;56:237-40.

World Health Organization. WHO model list of essential medi-cines: 17th list, March 2011.

Holmgren J, Svennerholm AM. Vaccines against mucosal in-fections. Current opinion in immunology. 2012 Jun 1;24(3):343-53. Doi: PMid:22580196

DeRoeck D, OchiaiRL, Yang J, Anh DD, Alag V, Clemens JD. Typhoid vaccination: the Asian experience. Expert review of vaccines. 2008 Jul 1;7(5):547-60. Doi: PMid:18564010

Hepatomegaly. Pediatrics Clerkship. The University of Chicago. Accessed on June 10 2019.

Splenomegaly | Pediatrics Clerkship | The University of Chica-go. Accessed on May 13 2019.

World Health Organisation. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity Available on Accessed on June 21, 2019.

Newburger PE, Dale DC. Evaluation and management of pa-tients with isolated neutropenia. SeminHematol. 2013;50(3):198-206. Doi: PMid:23953336 PMCid:PMC3748385

Bhan MK, Bahl R, Bhatnagar S. Typhoid and para typhoid fe-ver. Lancet 2005;366:749-62. Doi: PMid:16125594

Voysey M and Pollard AJ. Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV). Clin Infect Dis. 2018; Doi: PMid:29351594

Klugman KP et al. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysac-charide vaccine three years after immunization. Vaccine. 1996;14:435-438. Doi: PMid:8735556

Public health response to biological and chemical weapons. Geneva: WHO; 2004. World Health Organisation.

BioMed India. Vi conjugate typhoid vaccine. Available from:, accessed on May 30, 2019.

Jackson BR, Iqbal S, Mahon B. Updated recommendations for the use of typhoid vaccine-Advisory Committee on Immuniza-tion Practices, United States, 2015. MMWR. Morbidity and mortality weekly report. 2015 Mar 27;64(11):305.

Taneja PN, Ghai K. Clinical study of enteric fever. Indian Pediatr 1997;34(6):237-9.

Saxena PN, Sharma NL. Clinical study of enteric fever. Indian Pediatr 1967;4(12):439-45.

Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Ty-phoid fever. N. Engl. J. Med. 2002;347:1770-1782. Doi: PMid:12456854




How to Cite

Patel, N., Sasani, K., & Shah, S. (2024). Comparative Analysis of Vaccination Status in Enteric Fever: Correlating Clinical and Laboratory Parameters. National Journal of Medical Research, 14(01), 23–28.



Original Research Articles